Skip to content

Goal-directed Fluid Resuscitation in Acute Pancreatitis

A Randomized-controlled Trial of a Targeted Approach to Fluid Resuscitation in Acute Pancreatitis

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00853515
Enrollment
40
Registered
2009-03-02
Start date
2009-03-31
Completion date
2010-06-30
Last updated
2016-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis

Brief summary

Vigorous fluid resuscitation is currently believed to play a key role in reducing complications associated with acute pancreatitis. However, aggressive fluid replacement can be associated with complications such as pulmonary fluid sequestration. The purpose of this study is to evaluate alternative approaches to early fluid resuscitation for patients with acute pancreatitis.

Detailed description

Primary Aim: Evaluate the impact of a goal-directed fluid resuscitation protocol compared to standard fluid resuscitation on systemic inflammation in patients with acute pancreatitis. Secondary Aim: Evaluate the impact of resuscitation with Lactated Ringer's compared to normal saline on systemic inflammation in acute pancreatitis.

Interventions

OTHERGoal-directed fluid resuscitation

Targeted, weight-based fluid resuscitation

Sponsors

Dartmouth-Hitchcock Medical Center
CollaboratorOTHER
Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* acute pancreatitis diagnosed by at least 2 criteria * adult patients at least 18 years of age

Exclusion criteria

* history of severe cardiovascular, respiratory, renal, hepatic or hematologic/immunologic disease * concurrent metabolic or physiologic derangement requiring specific fluid management * pregnancy * patients transferred from acute care hospital

Design outcomes

Primary

MeasureTime frame
Prevalence (point prevalence) of the systemic inflammatory response syndrome (SIRS) at 24 hoursfirst 24 hours of hospitalization

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026